AI Mammography Solution 'Lunit Insight MMG' Approved in Taiwan
Lunit's artificial intelligence (AI) mammography image analysis solution 'Lunit Insight MMG' (Photo by Lunit)
View original image[Asia Economy Reporter Chunhee Lee] Lunit announced on the 25th that its mammography image analysis solution, 'Lunit Insight MMG,' recently obtained medical device sales approval (Class Ⅱ Medical Device) from the Taiwan Food and Drug Administration (TFDA).
Lunit Insight MMG is an artificial intelligence (AI)-based product that detects the presence of breast cancer in mammography images. It detects suspicious areas with 96% accuracy and assists medical professionals by providing location information and numerical indicators of the suspicion level. Lunit Insight MMG previously received sales approval from major countries, including the U.S. Food and Drug Administration (FDA) last year and Health Canada in June.
The Taiwanese medical device market is gradually expanding due to an increasing elderly population and a growing proportion of imported advanced medical devices. As of last year, the Taiwanese medical device market size was 77.785 billion Taiwan dollars (approximately 3.4389 trillion Korean won), maintaining an annual growth rate of about 3%.
Dr. Ye Wei-cheng of Nantou Hospital in Taiwan, who is currently using Lunit Insight MMG, stated, "We decided to adopt Lunit Insight MMG to increase the speed of mammography interpretation and reduce the possibility of misdiagnosis." He added, "Lunit Insight MMG is particularly effective for diagnosing dense breasts, which are common among East Asian women, and it facilitates accurate and smooth communication among specialists."
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Whistleblowers Could Earn Tens of Billions by Reporting Collusion... KFTC Announces Administrative Notice to Abolish Reward Cap
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Seobum Seok, CEO of Lunit, said, "Lunit Insight MMG provides patients with opportunities for fast and accurate treatment while simultaneously improving the convenience of medical professionals." He added, "This sales approval in Taiwan is expected to serve as a foothold for expanding into the Greater China market."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.